ES2188992T3 - Gen del crecimiento humano y region del gen de baja estatura. - Google Patents
Gen del crecimiento humano y region del gen de baja estatura.Info
- Publication number
- ES2188992T3 ES2188992T3 ES97944906T ES97944906T ES2188992T3 ES 2188992 T3 ES2188992 T3 ES 2188992T3 ES 97944906 T ES97944906 T ES 97944906T ES 97944906 T ES97944906 T ES 97944906T ES 2188992 T3 ES2188992 T3 ES 2188992T3
- Authority
- ES
- Spain
- Prior art keywords
- gene
- man
- phenotype
- stature
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 102000009331 Homeodomain Proteins Human genes 0.000 abstract 1
- 108010048671 Homeodomain Proteins Proteins 0.000 abstract 1
- 208000020221 Short stature Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2763396P | 1996-10-01 | 1996-10-01 | |
| EP97100583 | 1997-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2188992T3 true ES2188992T3 (es) | 2003-07-01 |
Family
ID=26145174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97944906T Expired - Lifetime ES2188992T3 (es) | 1996-10-01 | 1997-09-29 | Gen del crecimiento humano y region del gen de baja estatura. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7252974B2 (OSRAM) |
| EP (2) | EP0946721B1 (OSRAM) |
| JP (2) | JP2000515025A (OSRAM) |
| KR (1) | KR20000048838A (OSRAM) |
| CN (1) | CN1232499A (OSRAM) |
| AT (1) | ATE230026T1 (OSRAM) |
| AU (1) | AU744188C (OSRAM) |
| BR (1) | BR9712185A (OSRAM) |
| CA (2) | CA2647169A1 (OSRAM) |
| CZ (1) | CZ297640B6 (OSRAM) |
| DE (1) | DE69718052T2 (OSRAM) |
| DK (1) | DK0946721T3 (OSRAM) |
| ES (1) | ES2188992T3 (OSRAM) |
| HU (1) | HU225131B1 (OSRAM) |
| IL (1) | IL129015A0 (OSRAM) |
| NO (1) | NO991554L (OSRAM) |
| NZ (1) | NZ334970A (OSRAM) |
| PL (1) | PL194248B1 (OSRAM) |
| SI (1) | SI0946721T1 (OSRAM) |
| WO (1) | WO1998014568A1 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4011100A (en) * | 1999-03-19 | 2000-10-09 | Human Genome Sciences, Inc. | 48 human secreted proteins |
| JP2003535571A (ja) * | 1999-03-26 | 2003-12-02 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ５０個のヒト分泌タンパク質 |
| US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
| EP1573024A4 (en) | 2001-04-10 | 2007-08-29 | Agensys Inc | NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES |
| US20040248132A1 (en) | 2001-10-04 | 2004-12-09 | Toshiyuki Sakai | DR5 gene promoter and siah-1 gene promoter |
| EP1583554A2 (en) * | 2003-01-13 | 2005-10-12 | Gudrun Rappold-Hoerbrand | Use of natriuretic peptides for the treatment of stature disorders related to the shox gene |
| CA2606296C (en) | 2005-04-15 | 2019-05-21 | Epigenomics Ag | Methods and nucleic acids for analyses of cellular proliferative disorders |
| US7382944B1 (en) | 2006-07-14 | 2008-06-03 | The United States Of America As Represented By The Administration Of The National Aeronautics And Space Administration | Protective coating and hyperthermal atomic oxygen texturing of optical fibers used for blood glucose monitoring |
| ATE549418T1 (de) * | 2007-01-19 | 2012-03-15 | Epigenomics Ag | Verfahren und nukleinsäuren zur analyse proliferativer zellerkrankungen |
| WO2014182595A1 (en) * | 2013-05-06 | 2014-11-13 | Mikko Sofia | Diagnostic test for skeletal atavism in horses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3445933A1 (de) * | 1984-12-17 | 1986-06-19 | Röhm GmbH, 6100 Darmstadt | Arzneimittel mit diuretischer wirksamkeit |
| US4983511A (en) * | 1989-01-09 | 1991-01-08 | Olin Corporation | Method and kit for detecting live microorganisms in chlorine- or bromine-treated water |
-
1997
- 1997-09-29 AT AT97944906T patent/ATE230026T1/de active
- 1997-09-29 JP JP10516222A patent/JP2000515025A/ja active Pending
- 1997-09-29 WO PCT/EP1997/005355 patent/WO1998014568A1/en not_active Ceased
- 1997-09-29 AU AU46252/97A patent/AU744188C/en not_active Ceased
- 1997-09-29 HU HU9904175A patent/HU225131B1/hu not_active IP Right Cessation
- 1997-09-29 NZ NZ334970A patent/NZ334970A/xx unknown
- 1997-09-29 DE DE69718052T patent/DE69718052T2/de not_active Expired - Lifetime
- 1997-09-29 CZ CZ0096699A patent/CZ297640B6/cs not_active IP Right Cessation
- 1997-09-29 BR BR9712185-1A patent/BR9712185A/pt unknown
- 1997-09-29 CA CA002647169A patent/CA2647169A1/en not_active Abandoned
- 1997-09-29 EP EP97944906A patent/EP0946721B1/en not_active Expired - Lifetime
- 1997-09-29 CA CA002267097A patent/CA2267097A1/en not_active Abandoned
- 1997-09-29 CN CN97198471A patent/CN1232499A/zh active Pending
- 1997-09-29 ES ES97944906T patent/ES2188992T3/es not_active Expired - Lifetime
- 1997-09-29 IL IL12901597A patent/IL129015A0/xx unknown
- 1997-09-29 DK DK97944906T patent/DK0946721T3/da active
- 1997-09-29 KR KR1019990702836A patent/KR20000048838A/ko not_active Withdrawn
- 1997-09-29 EP EP02011329A patent/EP1260228A3/en not_active Withdrawn
- 1997-09-29 PL PL97332568A patent/PL194248B1/pl not_active IP Right Cessation
- 1997-09-29 SI SI9730485T patent/SI0946721T1/xx unknown
-
1999
- 1999-03-30 NO NO991554A patent/NO991554L/no not_active Application Discontinuation
-
2002
- 2002-05-31 US US10/158,160 patent/US7252974B2/en not_active Expired - Fee Related
-
2004
- 2004-03-02 JP JP2004058276A patent/JP2004201692A/ja active Pending
-
2007
- 2007-05-15 US US11/748,769 patent/US20090111744A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU744188B2 (en) | 2002-02-14 |
| DK0946721T3 (da) | 2003-04-14 |
| NO991554D0 (no) | 1999-03-30 |
| AU744188C (en) | 2003-07-24 |
| PL332568A1 (en) | 1999-09-27 |
| CA2647169A1 (en) | 1998-04-09 |
| IL129015A0 (en) | 2000-02-17 |
| EP1260228A3 (en) | 2003-03-05 |
| ATE230026T1 (de) | 2003-01-15 |
| WO1998014568A1 (en) | 1998-04-09 |
| CN1232499A (zh) | 1999-10-20 |
| DE69718052D1 (de) | 2003-01-30 |
| HUP9904175A2 (hu) | 2000-04-28 |
| EP1260228A2 (en) | 2002-11-27 |
| CZ297640B6 (cs) | 2007-02-21 |
| AU4625297A (en) | 1998-04-24 |
| CA2267097A1 (en) | 1998-04-09 |
| EP0946721B1 (en) | 2002-12-18 |
| HUP9904175A3 (en) | 2002-01-28 |
| EP0946721A1 (en) | 1999-10-06 |
| PL194248B1 (pl) | 2007-05-31 |
| US7252974B2 (en) | 2007-08-07 |
| JP2004201692A (ja) | 2004-07-22 |
| JP2000515025A (ja) | 2000-11-14 |
| NO991554L (no) | 1999-05-14 |
| US20090111744A1 (en) | 2009-04-30 |
| DE69718052T2 (de) | 2003-07-31 |
| CZ96699A3 (cs) | 1999-08-11 |
| KR20000048838A (ko) | 2000-07-25 |
| US20030059805A1 (en) | 2003-03-27 |
| NZ334970A (en) | 2000-12-22 |
| SI0946721T1 (en) | 2003-06-30 |
| BR9712185A (pt) | 1999-08-31 |
| HU225131B1 (en) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2188992T3 (es) | Gen del crecimiento humano y region del gen de baja estatura. | |
| Senger et al. | Microdissection of banded human chromosomes | |
| Shaffer et al. | Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme. | |
| Altshuller et al. | Gcm1, a mammalian homolog of Drosophila glial cells missing | |
| Morange et al. | Altered expression of heat shock proteins in embryonal carcinoma and mouse early embryonic cells | |
| Weskamp et al. | A family of cellular proteins related to snake venom disintegrins. | |
| Pickard et al. | Epigenetic targeting in the mouse zygote marks DNA for later methylation: a mechanism for maternal effects in development | |
| Leonhardt et al. | Structure, function and regulation of mammalian DNA methyltransferase | |
| ATE471373T1 (de) | Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna | |
| Wilcox et al. | Comparative mapping identifies the fusion point of an ancient mammalian X-autosomal rearrangement | |
| Hirai et al. | FISH techniques for constructing physical maps on schistosome chromosomes | |
| WO2002048329A3 (en) | Membrane derived caspase-3, compositions comprising the same and methods of use therefor | |
| Yi et al. | Bcl‐rambo beta, a special splicing variant with an insertion of an Alu‐like cassette, promotes etoposide‐and Taxol‐induced cell death | |
| Brown et al. | Beyond sense: the role of antisense RNA in controlling Xist expression | |
| Schmid et al. | Sperm nuclear matrix association of the PRM1→ PRM2→ TNP2 domain is independent of Alu methylation | |
| D’Cruz et al. | Putative imprinted gene expression in uniparental bovine embryo models | |
| Beinert et al. | Systematic gene targeting on the X chromosome of Drosophila melanogaster | |
| Redeker et al. | Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith-Wiedemann syndrome associated chromosomal breakpoints at 11p15. 3 | |
| Kraemer et al. | The new gene DmX from Drosophila melanogaster encodes a novel WD-repeat protein | |
| Mullan et al. | Uncovering BRCAI-regulated signalling pathways by microarray-based expression profiling | |
| Krieser et al. | Deoxyribonuclease II: structure and chromosomal localization of the murine gene, and comparison with the genomic structure of the human and three C. elegans homologs | |
| ATE348893T1 (de) | Tgc-verfahren zur induktion einer zielgerichteten,somatischen transgenität | |
| Tsipouras et al. | Genetic distance of two fibrillar collagen loci, COL3A1 and COL5A2, located on the long arm of human chromosome 2 | |
| Baron et al. | GNAI3, GNAT2, AMPD2, GSTM are clustered in 120 kb of Chinese hamster chromosome 1q | |
| Dixon et al. | Assignment of human B2-1 gene (D17S811E) to chromosome 17qter by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization |